Stephen Taub Premium Hedge Fund VC Activity Reveals Biopharma’s Fading Momentum RA Capital, Perceptive, and others scale back deals in life sciences—reflecting a broader slowdown in the sector after last year’s brief rebound. Stephen Taub August 5, 2025